Page last updated: 2024-11-08

1-oxoisoindole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

1-oxoisoindole: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID191109
CHEMBL ID352926
SCHEMBL ID113314
MeSH IDM0063494

Synonyms (13)

Synonym
1-oxoisoindole
bdbm50137366
1h-isoindol-1-one
CHEMBL352926 ,
isoindol-1-one
45738-06-5
isoindolone
AKOS006313837
SCHEMBL113314
XTBAPWCYTNCZTO-UHFFFAOYSA-N
1h-isoindolone
DTXSID80196612
FT-0734302
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Poly [ADP-ribose] polymerase 1 Mus musculus (house mouse)IC50 (µMol)30.00000.40000.42000.4400AID162567
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID162567Tested for inhibition of poly(ADP-ribose) polymerase-1 (PARP-1) in mouse using Cell protection assay2004Bioorganic & medicinal chemistry letters, Jan-05, Volume: 14, Issue:1
The discovery and synthesis of novel adenosine substituted 2,3-dihydro-1H-isoindol-1-ones: potent inhibitors of poly(ADP-ribose) polymerase-1 (PARP-1).
AID162569Percent inhibition of poly(ADP-ribose) polymerase-1 (PARP-1) in mouse using Cell protection assay at 10 uM2004Bioorganic & medicinal chemistry letters, Jan-05, Volume: 14, Issue:1
The discovery and synthesis of novel adenosine substituted 2,3-dihydro-1H-isoindol-1-ones: potent inhibitors of poly(ADP-ribose) polymerase-1 (PARP-1).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (32)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (6.25)18.2507
2000's5 (15.63)29.6817
2010's23 (71.88)24.3611
2020's2 (6.25)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (3.13%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other31 (96.88%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]